Home Nonprofit finds new cholesterol drugs far too costly
 

Keywords :   


Nonprofit finds new cholesterol drugs far too costly

2015-09-09 18:26:53| Biotech - Topix.net

An independent nonprofit organization that evaluates clinical and cost effectiveness of new medicines said announced prices for a just-approved class of potent cholesterol lowering drugs were far too high, according to a draft report released on Tuesday. The Boston-based Institute for Clinical and Economic Review said its analyses indicated "that the price that best represents the overall benefits" the drugs may provide patients would be between $3,615 and $4,811 a year, a 67 percent discount off the list prices.

Tags: too drugs finds nonprofit

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11ProjectDIVAF
23.11MtG
23.11THUNDER TRUCKS HOLLOW II 148
23.11 the Tiger 7 EP
23.11 11 LEGACY
23.11 GENOCIDE
23.11HG PART1 PART2
More »